Another short teaser from the Medical Update interview series, this one on the pace of weight loss with GLP-1 drugs. The full episode is on Spotify.
Recap by typeshit. Post by @medicalupdateonline on Instagram.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Fridges that can hold medication and higher-protein menus are among the new requests Fast Company highlights from the Priceline findings.
Data presented at EASD found the daily orforglipron pill had cardiovascular safety comparable to daily glargine shots in higher-risk adults with type 2 diabetes.
Loading…